Thousands to Walk Ahead for Brain Tumor Research Sunday
CINCINNATIOn Sunday, Oct. 25, more than 3,000 walkers and runners will pound the pavement in the sixth annual Walk Ahead for a Brain Tumor Cure. Already, the 2015 Walk Ahead has raised more than $276,000 for education and research at the Brain Tumor Center at the University of Cincinnati (UC) Neuroscience Institute and the UC Cancer Institute. The institutes are collaborations of the UC College of Medicine and UC Health.
Walk Ahead for a Brain Tumor Cure has raised more than $1.2 million for Cincinnati programs since its inception in 2010.
An estimated 215,000 brain tumors are diagnosed in the United States each year; of these, 45,000 have originated in the brain and 170,000 have metastasized from other parts of the body.
Patients, physicians and researchers of the UC Brain Tumor Center will be available for interviews before, during and after the Oct. 25 event.
Walk Ahead 5k Schedule
7 a.m.: Same-day registration opens
8 a.m.: Shotgun start for chip-timed 5K run, beginning at Yeatmans Cove, Sawyer Point
8:45 a.m.: Shotgun start for 5k walk, beginning at Yeatmans Cove, Sawyer Point
More information:
Related Stories
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.
UC graduates cross finish line at commencement
August 7, 2026
The University of Cincinnati recognized 2,125 graduates in two ceremonies at summer commencement Friday on campus at Fifth Third Arena.